Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry PerspectiveHardik Mody, Vijay Upreti, Prathap Nagaraja Shastri et al.|Clinical Pharmacology & Therapeutics|2023Cited by 26
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position PaperUma Kavita, Nagendra Chemuturi, Kefeng Sun et al.|The AAPS Journal|2023Cited by 17